p16-positive small cell neuroendocrine carcinoma of the endometrium

International Journal of Gynecological Pathology

Volumn 25, Issue 3, 2006, Pages 252-256

  Melgoza, Frank ^a,d   Brewster, Wendy R ^a   Wilczynski, Sharon ^b   Rutgers, Joanne ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

^d Building 10 ^*  (United States)

Author keywords

Cervical; Endometrial; Human papillomavirus (HPV); p16; Small cell neuroendocrine carcinoma

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; PROTEIN P16; PROTEIN P14ARF; VIRUS DNA;

ARTICLE; CASE REPORT; ENDOMETRIUM CARCINOMA; ENDOMETRIUM SMALL CELL NEUROENDOCRINE CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL CELL CARCINOMA; STAINING; UTERINE CERVIX; UTERINE CERVIX CANCER; WART VIRUS; BIOPSY; CARCINOMA; CHEMISTRY; ENDOMETRIUM TUMOR; GENETICS; PAPILLOMA VIRUS; PATHOLOGY;

BIOPSY; CARCINOMA, NEUROENDOCRINE; CARCINOMA, SMALL CELL; DNA, VIRAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PAPILLOMAVIRIDAE; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 33747178984     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000189242.11404.ae     Document Type: Article

References (23)

1. Katahira A, Akahira J, Niikura H, et al. Small cell carcinoma of the endometrium: report of three cases and literature review. Int J Gynecol Cancer 2004;14:1018-23.
2. Eichhorn JH, Young RH. Neuroendocrine tumors of the genital tract. Am J Clin Pathol 2001;115(Suppl 1):S94-112.
3. van Hoeven KH, Hudock JA, Woodruff JM, et al. Small cell carcinoma of the endometrium. Int J Gynecol Pathol 1995;14:21-9.
4. Sherr CJ, McCormick F. The Rb and p53 pathways in cancer. Cancer Cell 2002;2:103-12.
5. Li Y, Nichols MA, Shay JW, et al. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 1994;54:6078-82.
6. Ishida GM, Kato N, Hayasaka T, et al. Small cell neuroendocrine carcinomas of the uterine cervix: a histological, immunohistochemical, and molecular genetic study. Int J Gynecol Pathol 2004;23:366-72.
7. Stoler MH, Mills SE, Gersell DJ, et al. Small-cell neuroendocrine carcinoma of the cervix. A Human papillomavirus type 18-associated cancer. Am J Surg Pathol 1991;15:28-32.
8. Munger K, Howley PM. Human papillomavirus immortalization and transformation functions. Virus Res 2002;89:213-28.
9. Wang HL, Lu DW. Detection of human papilloma virus DNA and expression of p16, Rb, and p53 proteins in small cell carcinomas of the uterine cervix. Am J Surg Pathol 2004;28:901-8.
10. Resnick RM, Cornelissen MTE, Wright DK, et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990;82:1477-84.
11. Sarkar RH, Crissman JD. Detection of human papillomavirus DNA sequences by polymerase chain reaction. Biotechniques 1990;9:180-3.
12. Albores-Saavedra J, Latif S, Carrick KS, et al. CD56 reactivity in small cell carcinoma of the uterine cervix. Int J Gynecol Pathol 2005;24:113-7.
13. Huntsman DG, Clement PB, Gilks CB, et al. Small cell carcinoma of the endometrium. A clinicopathological study of sixteen cases. Am J Surg Pathol 1994;18:364-75.
14. Helt AM, Galloway DA. Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 2003;24:159-69.
15. Sherr CJ. The Ink4a/ARF network in tumour suppression. Nature 2001;2:731-7.
16. Kaye FJ. RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer. Oncogene 2002;21:6908-14.
17. Dimri GP, Itahana K, Acosta M, et al. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14ARF tumor suppressor. Mol Cell Biol 2000;20:273-85.
18. Beasley MB, Lantuejoul S, Abbondanzo S, et al. The p16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung. Hum Pathol 2003;34:136-42.
19. Bartek J, Lukas J. Mammalian G1-and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol 2001;13:738-47.
20. Semczuk A, Boltze C, Marzec B, et al. p16 Ink4a alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas. J Cancer Res Clin Oncol 2003;129:589-96.
21. Ansari-Lari MA, Staebler A, Zaino RJ, et al. Distinction of endocervical and endometrial adenocarcinoma. Immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection. Am J Surg Pathol 2004;28:160-7.
22. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-84.
23. Brewster WR, Monk BJ, Burger RA, et al. Does human papillomavirus have a role in cancers of the uterine corpus? Gynecol Oncol 1999;75:51-4.